首页 > 最新文献

International Journal of Cardiovascular Sciences最新文献

英文 中文
General Approach to Acute Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): A Systematic Review 急性心肌梗死合并非阻塞性冠状动脉(MINOCA)的一般入路:系统回顾
Q4 Medicine Pub Date : 2023-05-15 DOI: 10.36660/ijcs.20220046
Marcos Aurélio Barboza de Oliveira, Á. Osti, Bruno Vargas Teixeira Cavalheiro, Déborah Barbosa Naves, Emanuelle Ribeiro de Oliveira, Gabriel Freitas de Campos, Gabriel Mael Sussuarana Silva Lobo, Gabriely DE Oliveira, Marcela Paula Mainardi, Marília Cardoso Guimarães, R. F. Barbosa, Vilian Veloso de Moura Fé
Background: Acute myocardial infarction (AMI) without obstructive coronary arteries (MINOCA) is a medical condition of great relevance, with clinical characteristics of AMI, but without evidence of coronary artery obstruction. The mechanism involved in the pathophysiology of the disease and its possible etiologies are important objects of study due to their impact on the morbidity and mortality of affected patients. Objectives : The aim of this study was to systematically review MINOCA and its characteristics, with emphasis on the clinical profile of patients, etiology, pathophysiology, diagnosis, and treatment of the syndrome. Methods : Relevant articles related to MINOCA were analyzed in the PubMed and LILACS databases. In the initial search stage, 619 eligible articles were obtained, with final inclusion criteria being: original systematic reviews with clinical, epidemiological, diagnostic, or treatment data on MINOCA, published in Portuguese or English, with an abstract, and a publication date limit of September 2020. Results : A total of 10 articles classified as systematic reviews that considered clinical data on MINOCA were included in this review. Conclusion : After analyzing various literature, the present study provided a tool to better understand MINOCA, not only regarding its casuistry but also in grouping parameters and information that contribute to a healthy approach to this clinical situation. It was possible to identify and better outline the clinical profile of patients who presented this condition and the use of appropriate tools for correct diagnosis and ideal treatment.
背景:急性心肌梗死(AMI)无冠状动脉梗阻(MINOCA)是一种非常相关的医学疾病,具有AMI的临床特征,但没有冠状动脉阻塞的证据。该疾病的病理生理机制及其可能的病因是重要的研究对象,因为它们影响患者的发病率和死亡率。目的:本研究的目的是系统地回顾MINOCA及其特征,重点是患者的临床特征、病因、病理生理、诊断和治疗。方法:对PubMed和LILACS数据库中与MINOCA相关的文献进行分析。在初始检索阶段,获得了619篇符合条件的文章,最终纳入标准为:包含MINOCA临床、流行病学、诊断或治疗数据的原始系统综述,以葡萄牙语或英语发表,附摘要,出版日期限制为2020年9月。结果:本综述共纳入了10篇纳入MINOCA临床数据的系统评价文章。结论:在分析了各种文献后,本研究提供了一个更好地了解MINOCA的工具,不仅是在其诡辩性方面,而且在分组参数和信息方面,有助于健康地对待这种临床情况。有可能识别并更好地概述出现这种情况的患者的临床概况,并使用适当的工具进行正确的诊断和理想的治疗。
{"title":"General Approach to Acute Myocardial Infarction with Nonobstructive Coronary Arteries (MINOCA): A Systematic Review","authors":"Marcos Aurélio Barboza de Oliveira, Á. Osti, Bruno Vargas Teixeira Cavalheiro, Déborah Barbosa Naves, Emanuelle Ribeiro de Oliveira, Gabriel Freitas de Campos, Gabriel Mael Sussuarana Silva Lobo, Gabriely DE Oliveira, Marcela Paula Mainardi, Marília Cardoso Guimarães, R. F. Barbosa, Vilian Veloso de Moura Fé","doi":"10.36660/ijcs.20220046","DOIUrl":"https://doi.org/10.36660/ijcs.20220046","url":null,"abstract":"Background: Acute myocardial infarction (AMI) without obstructive coronary arteries (MINOCA) is a medical condition of great relevance, with clinical characteristics of AMI, but without evidence of coronary artery obstruction. The mechanism involved in the pathophysiology of the disease and its possible etiologies are important objects of study due to their impact on the morbidity and mortality of affected patients. Objectives : The aim of this study was to systematically review MINOCA and its characteristics, with emphasis on the clinical profile of patients, etiology, pathophysiology, diagnosis, and treatment of the syndrome. Methods : Relevant articles related to MINOCA were analyzed in the PubMed and LILACS databases. In the initial search stage, 619 eligible articles were obtained, with final inclusion criteria being: original systematic reviews with clinical, epidemiological, diagnostic, or treatment data on MINOCA, published in Portuguese or English, with an abstract, and a publication date limit of September 2020. Results : A total of 10 articles classified as systematic reviews that considered clinical data on MINOCA were included in this review. Conclusion : After analyzing various literature, the present study provided a tool to better understand MINOCA, not only regarding its casuistry but also in grouping parameters and information that contribute to a healthy approach to this clinical situation. It was possible to identify and better outline the clinical profile of patients who presented this condition and the use of appropriate tools for correct diagnosis and ideal treatment.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"75 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86653303","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sociodemographic Profile of Acute Myocardial Infarction in Rio De Janeiro, Brazil (2010-2019) 巴西里约热内卢急性心肌梗死的社会人口统计特征(2010-2019)
Q4 Medicine Pub Date : 2023-05-15 DOI: 10.36660/ijcs.20210275
L. A. D. Carvalho
Background: Cardiovascular Diseases (CVDs) are the main cause of mortality in Brazil, which includes acute myocardial infarction (AMI). In 2017, 12% of deaths caused by infarction in Brazil occurred in the state of Rio de Janeiro, characterizing it as an important “hotspot” in the country. Objectives : This study aimed to characterize the population affected by AMI over the past decade within the state so as to guide future public policies related to CVDs. Methods : Secondary data of patients affected by AMI between 2010 and 2019 were obtained by DATASUS. In-hospital case-fatality rates, mortality rates, and proportional mortality were calculated using information gathered by the Mortality Information System (SIM) and demographic statistics produced by the Brazilian Institute of Geography and Statistics (IBGE). Results : The main results showed that in-hospital case-fatality rates were higher in women, patients aged 60 years and over, the black color/race, and the state's Northwest region. The mortality rate was higher among men, especially in the South-central region and those over 50 years of age. People aged 40-49 years presented a considerable risk of death by infarction. The major categories of data classified as “ignored” in hospital admissions and death certificates were those related to race and education level. Conclusions : Prevention should not only focus on the elderly, but also on people over 40, especially men. The incompleteness of electronic public data systems can affect the use of race/color or education level as epidemiological variables. New studies should be conducted to understand why the South-central region is so heavily affected by infarction.
背景:心血管疾病(cvd)是巴西人死亡的主要原因,其中包括急性心肌梗死(AMI)。2017年,巴西12%的梗死死亡发生在里约热内卢州,使其成为该国重要的“热点”。目的:本研究旨在描述过去十年来该州受AMI影响的人群特征,以指导未来与心血管疾病相关的公共政策。方法:通过DATASUS获取2010 - 2019年AMI患者的二次资料。使用死亡率信息系统(SIM)收集的信息和巴西地理与统计研究所(IBGE)提供的人口统计数据计算住院病死率、死亡率和比例死亡率。结果:主要结果表明,妇女、60岁及以上患者、黑人/种族和该州西北地区的住院病死率较高。男性的死亡率较高,特别是在中南部地区和50岁以上的男性。40-49岁的人有相当大的梗死死亡风险。住院和死亡证明中被列为"被忽视"的主要数据类别是那些与种族和教育水平有关的数据。结论:预防不应只针对老年人,而应针对40岁以上人群,尤其是男性。电子公共数据系统的不完备会影响种族/肤色或教育水平作为流行病学变量的使用。应该进行新的研究,以了解为什么中南部地区受到梗塞的影响如此严重。
{"title":"Sociodemographic Profile of Acute Myocardial Infarction in Rio De Janeiro, Brazil (2010-2019)","authors":"L. A. D. Carvalho","doi":"10.36660/ijcs.20210275","DOIUrl":"https://doi.org/10.36660/ijcs.20210275","url":null,"abstract":"Background: Cardiovascular Diseases (CVDs) are the main cause of mortality in Brazil, which includes acute myocardial infarction (AMI). In 2017, 12% of deaths caused by infarction in Brazil occurred in the state of Rio de Janeiro, characterizing it as an important “hotspot” in the country. Objectives : This study aimed to characterize the population affected by AMI over the past decade within the state so as to guide future public policies related to CVDs. Methods : Secondary data of patients affected by AMI between 2010 and 2019 were obtained by DATASUS. In-hospital case-fatality rates, mortality rates, and proportional mortality were calculated using information gathered by the Mortality Information System (SIM) and demographic statistics produced by the Brazilian Institute of Geography and Statistics (IBGE). Results : The main results showed that in-hospital case-fatality rates were higher in women, patients aged 60 years and over, the black color/race, and the state's Northwest region. The mortality rate was higher among men, especially in the South-central region and those over 50 years of age. People aged 40-49 years presented a considerable risk of death by infarction. The major categories of data classified as “ignored” in hospital admissions and death certificates were those related to race and education level. Conclusions : Prevention should not only focus on the elderly, but also on people over 40, especially men. The incompleteness of electronic public data systems can affect the use of race/color or education level as epidemiological variables. New studies should be conducted to understand why the South-central region is so heavily affected by infarction.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"57 7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80117533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence of Atrial Fibrillation in Patients With end Stage Renal Disease 终末期肾病患者心房颤动的患病率
Q4 Medicine Pub Date : 2023-05-15 DOI: 10.36660/ijcs.20220143
Maria da Graça Lepre Hawerroth, Lucas Yuji Sonoda, Jean José Silva, Walter Alvarenga de Oliveira
Background: Atrial fibrillation (AF) is the most common arrhythmia in patients with end-stage renal disease (ESRD). The coexistence of high thromboembolic and hemorrhagic risks, added to the lack of strong scientific evidence on the safety of anticoagulants in the setting of renal failure, makes this a clinically challenging situation. Objectives : To describe the clinical-demographic profile and prevalence of AF in the population with ESRD undergoing dialysis. Secondary objectives include the assessment of thromboembolic (CHA 2 DS 2 VASC) and bleeding (HASBLED) risk scores. Methods : Cross-sectional analytical-descriptive study, carried out between January and March 2020. Patients with ESRD were evaluated by means of a medical history questionnaire, physical examination, and 12-lead electrocardiogram. A chi-square (χ2) association test was applied to calculate association between clinical variables and AF, with a significance level of α = 0.05. Results : This study evaluated 295 patients, most of whom were men (170), elderly (63, IQR 53-71), current smokers (130), with associated cardio-endocrine comorbidities. The prevalence of AF was 6.7% (20). Heart failure (HF) (χ2=15 . 417; p<0.001), age of 65 years or older (χ2=14 . 584; p<0.001), and anticoagulation (χ2=5 . 715; p<0.01) were associated with AF. The median CHA 2 DS 2 VASC and HASBLED was 4 and 3, respectively. Eight patients were taking warfarin and five were receiving apixaban. Conclusion : The prevalence of AF in this study is similar to that reported in other published articles on the subject, and patients were at high risk for cardiovascular outcomes. Non-anticoagulation strategy was commonly adopted due to controversies in the literature as well as the absence of published randomized clinical trials.
背景:房颤(AF)是终末期肾病(ESRD)患者最常见的心律失常。高血栓栓塞和出血风险并存,再加上缺乏强有力的科学证据表明抗凝剂在肾衰竭患者中的安全性,使得这成为一个具有挑战性的临床情况。目的:描述接受透析的ESRD患者的临床人口学特征和房颤患病率。次要目标包括评估血栓栓塞(CHA 2 DS 2 VASC)和出血(HASBLED)风险评分。方法:横断面分析-描述性研究,于2020年1月至3月进行。通过病史问卷、体格检查和12导联心电图对ESRD患者进行评估。采用χ2关联检验计算临床变量与房颤的相关性,显著性水平为α = 0.05。结果:本研究评估了295例患者,其中大多数为男性(170例),老年人(63例,IQR 53-71),当前吸烟者(130例),伴有相关的心脏-内分泌合并症。房颤患病率为6.7%(20)。心力衰竭(HF) (χ2=15。417;P <0.001),年龄≥65岁(χ2=14)。584;P <0.001),抗凝治疗(χ2=5)。715;p<0.01)与房颤相关。CHA 2 ds2 VASC和HASBLED的中位值分别为4和3。8名患者服用华法林,5名患者服用阿哌沙班。结论:本研究中AF的患病率与其他已发表的有关该主题的文章相似,患者心血管结局的风险较高。由于文献中存在争议以及缺乏已发表的随机临床试验,通常采用非抗凝策略。
{"title":"Prevalence of Atrial Fibrillation in Patients With end Stage Renal Disease","authors":"Maria da Graça Lepre Hawerroth, Lucas Yuji Sonoda, Jean José Silva, Walter Alvarenga de Oliveira","doi":"10.36660/ijcs.20220143","DOIUrl":"https://doi.org/10.36660/ijcs.20220143","url":null,"abstract":"Background: Atrial fibrillation (AF) is the most common arrhythmia in patients with end-stage renal disease (ESRD). The coexistence of high thromboembolic and hemorrhagic risks, added to the lack of strong scientific evidence on the safety of anticoagulants in the setting of renal failure, makes this a clinically challenging situation. Objectives : To describe the clinical-demographic profile and prevalence of AF in the population with ESRD undergoing dialysis. Secondary objectives include the assessment of thromboembolic (CHA 2 DS 2 VASC) and bleeding (HASBLED) risk scores. Methods : Cross-sectional analytical-descriptive study, carried out between January and March 2020. Patients with ESRD were evaluated by means of a medical history questionnaire, physical examination, and 12-lead electrocardiogram. A chi-square (χ2) association test was applied to calculate association between clinical variables and AF, with a significance level of α = 0.05. Results : This study evaluated 295 patients, most of whom were men (170), elderly (63, IQR 53-71), current smokers (130), with associated cardio-endocrine comorbidities. The prevalence of AF was 6.7% (20). Heart failure (HF) (χ2=15 . 417; p<0.001), age of 65 years or older (χ2=14 . 584; p<0.001), and anticoagulation (χ2=5 . 715; p<0.01) were associated with AF. The median CHA 2 DS 2 VASC and HASBLED was 4 and 3, respectively. Eight patients were taking warfarin and five were receiving apixaban. Conclusion : The prevalence of AF in this study is similar to that reported in other published articles on the subject, and patients were at high risk for cardiovascular outcomes. Non-anticoagulation strategy was commonly adopted due to controversies in the literature as well as the absence of published randomized clinical trials.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"104 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76080643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biomarker-associated Monocyte Inflammatory Signaling in Myocardial Infarction 心肌梗死中与生物标志物相关的单核细胞炎症信号
Q4 Medicine Pub Date : 2023-04-21 DOI: 10.36660/ijcs.20220007
R. Guimarães, J. Marchini, Luz Marina Gómez Gómez, R. S. Leite, Ó. Dutra, Iran Castro, A. Manica
Background: Monocytes are essential components in inflammatory signaling, and their recruitment is crucial in the signaling pathway, which directs and determines cell adhesion to the activated endothelium. A better understanding of the correlation between monocyte subsets and inflammatory signaling in patients with atherosclerotic disease in acute coronary syndrome (ACS) is essential for the development of more effective therapies for the prevention and treatment of cardiovascular diseases. Objective: To analyze differences between biomarkers and monocyte activation in the setting of ischemic heart disease. Methods: This was a case-control study comparing biomarkers and monocyte subsets between patients with ACS with and without ST-segment elevation and individuals without coronary stenosis. The nonparametric Kruskal-Wallis test was used to assess differences between groups, and Dunn’s post hoc test was used to identify which groups were different. Cuzick’s test for ordered group trends was used to assess falling or rising trends. Participants were classified into 3 groups: control (0); non-ST-elevation myocardial infarction (NSTEMI) (1); ST-elevation myocardial infarction (STEMI) D1 (2). Results: Forty-seven patients with ACS and 19 controls with no obstructive lesions on coronary angiography were recruited. Monocyte profile assessment was statistically different regarding time of symptom onset and the presence or absence of atherosclerotic disease (Kruskal-Wallis, p = 0.0009). Dunn’s post hoc test showed a significant difference between the control group and the STEMI D1 (p = 0.0014), STEMI D3 (p = 0.0036), and STEMI D7 (p = 0.0195) groups, corresponding to a 2-fold increase in classical (p = 0.0022) and nonclassical (p = 0.0031) monocytes compared with controls. For classical monocytes, there was a difference between the control group and all STEMI groups and between the NSTEMI group and the STEMI D1, D3, and D7 groups. For nonclassical monocytes, there was a difference between the control group and the STEMI D7 group (p = 0.0056) and between the NSTEMI group and the STEMI D7 group (p = 0.0166). Conclusion: This study found that there was an increase in total and classical monocyte mobilization at the time of acute myocardial infarction in patients with ACS.
背景:单核细胞是炎症信号传导的重要组成部分,它们的募集在信号通路中起着至关重要的作用,它指导和决定了细胞对活化内皮的粘附。更好地了解急性冠脉综合征(ACS)动脉粥样硬化性疾病患者单核细胞亚群与炎症信号之间的相关性,对于开发更有效的预防和治疗心血管疾病的疗法至关重要。目的:分析缺血性心脏病患者生物标志物与单核细胞活化的差异。方法:这是一项病例对照研究,比较伴有和不伴有st段抬高的ACS患者与没有冠状动脉狭窄的患者之间的生物标志物和单核细胞亚群。非参数Kruskal-Wallis检验用于评估组间差异,Dunn事后检验用于确定哪些组存在差异。库兹克的有序群体趋势测试被用来评估下降或上升的趋势。参与者分为3组:对照组(0);非st段抬高型心肌梗死(NSTEMI) (1);st段抬高型心肌梗死(STEMI) D1(2)。结果:招募了47例ACS患者和19例对照组,冠状动脉造影无阻塞性病变。单核细胞谱评估在症状出现时间和有无动脉粥样硬化性疾病方面存在统计学差异(Kruskal-Wallis, p = 0.0009)。Dunn 's事后检验显示,对照组与STEMI D1组(p = 0.0014)、STEMI D3组(p = 0.0036)和STEMI D7组(p = 0.0195)之间存在显著差异,与对照组相比,经典(p = 0.0022)和非经典(p = 0.0031)单核细胞增加了2倍。对于经典单核细胞,对照组与所有STEMI组之间以及NSTEMI组与STEMI D1、D3和D7组之间存在差异。对于非经典单核细胞,对照组与STEMI D7组之间存在差异(p = 0.0056), NSTEMI组与STEMI D7组之间存在差异(p = 0.0166)。结论:本研究发现ACS患者急性心肌梗死时总单核细胞动员和经典单核细胞动员均增加。
{"title":"Biomarker-associated Monocyte Inflammatory Signaling in Myocardial Infarction","authors":"R. Guimarães, J. Marchini, Luz Marina Gómez Gómez, R. S. Leite, Ó. Dutra, Iran Castro, A. Manica","doi":"10.36660/ijcs.20220007","DOIUrl":"https://doi.org/10.36660/ijcs.20220007","url":null,"abstract":"Background: Monocytes are essential components in inflammatory signaling, and their recruitment is crucial in the signaling pathway, which directs and determines cell adhesion to the activated endothelium. A better understanding of the correlation between monocyte subsets and inflammatory signaling in patients with atherosclerotic disease in acute coronary syndrome (ACS) is essential for the development of more effective therapies for the prevention and treatment of cardiovascular diseases. Objective: To analyze differences between biomarkers and monocyte activation in the setting of ischemic heart disease. Methods: This was a case-control study comparing biomarkers and monocyte subsets between patients with ACS with and without ST-segment elevation and individuals without coronary stenosis. The nonparametric Kruskal-Wallis test was used to assess differences between groups, and Dunn’s post hoc test was used to identify which groups were different. Cuzick’s test for ordered group trends was used to assess falling or rising trends. Participants were classified into 3 groups: control (0); non-ST-elevation myocardial infarction (NSTEMI) (1); ST-elevation myocardial infarction (STEMI) D1 (2). Results: Forty-seven patients with ACS and 19 controls with no obstructive lesions on coronary angiography were recruited. Monocyte profile assessment was statistically different regarding time of symptom onset and the presence or absence of atherosclerotic disease (Kruskal-Wallis, p = 0.0009). Dunn’s post hoc test showed a significant difference between the control group and the STEMI D1 (p = 0.0014), STEMI D3 (p = 0.0036), and STEMI D7 (p = 0.0195) groups, corresponding to a 2-fold increase in classical (p = 0.0022) and nonclassical (p = 0.0031) monocytes compared with controls. For classical monocytes, there was a difference between the control group and all STEMI groups and between the NSTEMI group and the STEMI D1, D3, and D7 groups. For nonclassical monocytes, there was a difference between the control group and the STEMI D7 group (p = 0.0056) and between the NSTEMI group and the STEMI D7 group (p = 0.0166). Conclusion: This study found that there was an increase in total and classical monocyte mobilization at the time of acute myocardial infarction in patients with ACS.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"282 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83430348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Burden of Stroke in the Southeast Region of Brazil in 2019: an Estimate Based on Secondary Data from the Brazilian United Health System 2019年巴西东南地区卒中负担:基于巴西联合卫生系统二手数据的估计
Q4 Medicine Pub Date : 2023-04-21 DOI: 10.36660/ijcs.20220116
M. Reis, A. Chaoubah
,
{"title":"The Burden of Stroke in the Southeast Region of Brazil in 2019: an Estimate Based on Secondary Data from the Brazilian United Health System","authors":"M. Reis, A. Chaoubah","doi":"10.36660/ijcs.20220116","DOIUrl":"https://doi.org/10.36660/ijcs.20220116","url":null,"abstract":",","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81615861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Electrocardiogram as Part of the Evaluation of Children and Adolescents Before Starting Physical Exercise 心电图作为儿童和青少年开始体育锻炼前评估的一部分
Q4 Medicine Pub Date : 2023-04-21 DOI: 10.36660/ijcs.20220052
Diego Lineker Marquetto Silva, R. Bonatto, Celia de Paula Pimenta Bonatto, Carlos Roberto Padovani, J. Fioretto
Background: Children and adolescents should be encouraged to participate in sports; however, physicians should screen for cardiac abnormalities that can lead to sudden death. The European Society of Cardiology, the Brazilian Society of Cardiology and the Brazilian Society of Sports Medicine indicate performing an electrocardiogram (ECG) in evaluating athletes, while the American Heart Association indicates complementary exams only when there is a personal or family history of cardiovascular diseases or changes in clinical examination. Objectives : To evaluate the need for an ECG in evaluating children and adolescents before starting physical activities. Methods : We recruited 983 children and adolescents who practiced physical activities for anthropometric assessment, clinical examination and conventional ECG at rest. Variables were analysed using the Goodman test with a significance level of 5%. Results : Participants had a higher incidence of overweight, obesity and severe obesity compared to standard World Health Organization (WHO) values. The most common finding in clinical examination was heart murmur (18.5% of participants). Electrocardiographic changes were found in 3.3% of participants, including paroxysmal supraventricular tachycardia and pre-excitation syndrome, which may be responsible for sudden death, even in asymptomatic individuals with no personal or family history of heart disease and no abnormality on clinical examination. Conclusions : ECG revealed arrhythmias that were not detected by clinical examination and may precede sudden death in individuals subjected to physical exertion, indicating its role in the assessment of children and adolescents before starting regular physical exercise .
背景:应该鼓励儿童和青少年参加体育运动;然而,医生应该筛查可能导致猝死的心脏异常。欧洲心脏病学会、巴西心脏病学会和巴西运动医学学会建议在评估运动员时进行心电图(ECG),而美国心脏协会建议只有当有心血管疾病的个人或家族病史或临床检查有变化时才进行补充检查。目的:评价在开始体育活动前对儿童和青少年进行心电图评估的必要性。方法:我们招募了983名进行体育锻炼的儿童和青少年进行人体测量、临床检查和静息时的常规心电图。变量分析采用Goodman检验,显著性水平为5%。结果:与世界卫生组织(WHO)的标准值相比,参与者超重、肥胖和严重肥胖的发生率更高。临床检查中最常见的发现是心脏杂音(18.5%的参与者)。在3.3%的参与者中发现心电图改变,包括阵发性室上性心动过速和预兴奋综合征,这可能是猝死的原因,即使在没有个人或家族史的无症状个体中也是如此,临床检查也没有异常。结论:心电图显示临床检查未发现的心律失常,可能导致体力消耗的个体猝死,提示其在儿童和青少年开始定期体育锻炼前的评估中的作用。
{"title":"Electrocardiogram as Part of the Evaluation of Children and Adolescents Before Starting Physical Exercise","authors":"Diego Lineker Marquetto Silva, R. Bonatto, Celia de Paula Pimenta Bonatto, Carlos Roberto Padovani, J. Fioretto","doi":"10.36660/ijcs.20220052","DOIUrl":"https://doi.org/10.36660/ijcs.20220052","url":null,"abstract":"Background: Children and adolescents should be encouraged to participate in sports; however, physicians should screen for cardiac abnormalities that can lead to sudden death. The European Society of Cardiology, the Brazilian Society of Cardiology and the Brazilian Society of Sports Medicine indicate performing an electrocardiogram (ECG) in evaluating athletes, while the American Heart Association indicates complementary exams only when there is a personal or family history of cardiovascular diseases or changes in clinical examination. Objectives : To evaluate the need for an ECG in evaluating children and adolescents before starting physical activities. Methods : We recruited 983 children and adolescents who practiced physical activities for anthropometric assessment, clinical examination and conventional ECG at rest. Variables were analysed using the Goodman test with a significance level of 5%. Results : Participants had a higher incidence of overweight, obesity and severe obesity compared to standard World Health Organization (WHO) values. The most common finding in clinical examination was heart murmur (18.5% of participants). Electrocardiographic changes were found in 3.3% of participants, including paroxysmal supraventricular tachycardia and pre-excitation syndrome, which may be responsible for sudden death, even in asymptomatic individuals with no personal or family history of heart disease and no abnormality on clinical examination. Conclusions : ECG revealed arrhythmias that were not detected by clinical examination and may precede sudden death in individuals subjected to physical exertion, indicating its role in the assessment of children and adolescents before starting regular physical exercise .","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81814646","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Favorable Safety Experience of Local Dental Anesthesia in ICD Recipients with Cardiac Channelopathies 局部牙麻醉对心脏通道病变ICD受者的良好安全经验
Q4 Medicine Pub Date : 2023-04-03 DOI: 10.36660/ijcs.20200312
A. C. Oliveira, I. Neves, Luciana Sacilotto, N. Olivetti, S. Bueno, G. Pessente, M. A. Santos-Paul, T. Montano, Cíntia Maria Alencar de Carvalho, C. Grupi, S. Barbosa, C. Pastore, N. Samesima, T. Wu, D. Hachul, M. Scanavacca, R. Neves, F. Darrieux
Abstract Background Dental anesthetic management in implantable cardioverter defibrillator (ICD) recipients with cardiac channelopathies (CCh) can be challenging due to the potential risk of life-threatening arrhythmias and appropriate ICD therapies during procedural time. Objectives The present study assessed the hypothesis that the use of local dental anesthesia with 2% lidocaine with 1:100,000 epinephrine or without a vasoconstrictor can be safe in selected ICD and CCh patients, not resulting in life-threatening events (LTE). Methods Restorative dental treatment under local dental anesthesia was made in two sessions, with a wash-out period of 7 days (cross-over trial), conducting with a 28h - Holter monitoring, and 12-lead electrocardiography, digital sphygmomanometry, and anxiety scale assessments in 3 time periods. Statistical analysis carried out the paired Student’s t test and the Wilcoxon signed-rank test. In all cases, a significance level of 5% was adopted. All patients were in stable condition with no recent events before dental care. Results Twenty-four consecutive procedures were performed in 12 patients (9 women, 3 men) with CCh and ICD: 7 (58.3%) had long QT syndrome (LQTS), 4 (33.3%) Brugada syndrome (BrS), and 1 (8.3%) Catecholaminergic polymorphic ventricular tachycardia (CPVT). Holter analysis showed no increased heart rate (HR) or sustained arrhythmias. Blood pressure (BP), electrocardiographic changes and anxiety measurement showed no statistically significant differences. No LTE occurred during dental treatment, regardless of the type of anesthesia. Conclusion Lidocaine administration, with or without epinephrine, can be safely used in selected CCh-ICD patients without LTE. These preliminary findings need to be confirmed in a larger population with ICD and CCh.
{"title":"Favorable Safety Experience of Local Dental Anesthesia in ICD Recipients with Cardiac Channelopathies","authors":"A. C. Oliveira, I. Neves, Luciana Sacilotto, N. Olivetti, S. Bueno, G. Pessente, M. A. Santos-Paul, T. Montano, Cíntia Maria Alencar de Carvalho, C. Grupi, S. Barbosa, C. Pastore, N. Samesima, T. Wu, D. Hachul, M. Scanavacca, R. Neves, F. Darrieux","doi":"10.36660/ijcs.20200312","DOIUrl":"https://doi.org/10.36660/ijcs.20200312","url":null,"abstract":"Abstract Background Dental anesthetic management in implantable cardioverter defibrillator (ICD) recipients with cardiac channelopathies (CCh) can be challenging due to the potential risk of life-threatening arrhythmias and appropriate ICD therapies during procedural time. Objectives The present study assessed the hypothesis that the use of local dental anesthesia with 2% lidocaine with 1:100,000 epinephrine or without a vasoconstrictor can be safe in selected ICD and CCh patients, not resulting in life-threatening events (LTE). Methods Restorative dental treatment under local dental anesthesia was made in two sessions, with a wash-out period of 7 days (cross-over trial), conducting with a 28h - Holter monitoring, and 12-lead electrocardiography, digital sphygmomanometry, and anxiety scale assessments in 3 time periods. Statistical analysis carried out the paired Student’s t test and the Wilcoxon signed-rank test. In all cases, a significance level of 5% was adopted. All patients were in stable condition with no recent events before dental care. Results Twenty-four consecutive procedures were performed in 12 patients (9 women, 3 men) with CCh and ICD: 7 (58.3%) had long QT syndrome (LQTS), 4 (33.3%) Brugada syndrome (BrS), and 1 (8.3%) Catecholaminergic polymorphic ventricular tachycardia (CPVT). Holter analysis showed no increased heart rate (HR) or sustained arrhythmias. Blood pressure (BP), electrocardiographic changes and anxiety measurement showed no statistically significant differences. No LTE occurred during dental treatment, regardless of the type of anesthesia. Conclusion Lidocaine administration, with or without epinephrine, can be safely used in selected CCh-ICD patients without LTE. These preliminary findings need to be confirmed in a larger population with ICD and CCh.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"5 8 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75624760","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Clinical Aspects Of Hypertensive Patients With COVID-19 Hospitalized In A Campaign Hospital In Northeast Brazil 巴西东北部某运动医院新冠肺炎住院高血压患者的临床特点
Q4 Medicine Pub Date : 2023-04-03 DOI: 10.36660/ijcs.20220033
Luan George Xavier, Renato Sampaio Mello, Marcos Henrique de Oliveira Morais, Pedro Jorge Luz Alves Cronemberger, M. D. C. C. Martins, M. Rosal
Abstract Background In view of the absence of effective therapy for COVID-19, many studies have been conducted seeking to identify determining factors for the development of severe forms, aiming to direct efforts to avoid the worst outcomes in patients susceptible to severe conditions. One of the main comorbidities associated with complicated forms of the disease is systemic arterial hypertension (SAH). Objective To assess aspects of the clinical, demographic, laboratory, and radiological characteristics of hypertensive patients with COVID-19 to contribute to the knowledge of the relationship between the presence of this comorbidity and the severity of the disease. Methods A total of 380 patients with a diagnosis of acute SARS-CoV-2 infection hospitalized between June and August 2020 were included. Patients were divided into two groups according to the presence or absence of a previous diagnosis of hypertension. For comparison between groups, a significant difference was established if p < 0.05. Results Of the total of 380 patients, 202 (53.16%) had a clinical diagnosis of SAH. Hypertensive patients were significantly older (p < 0.01) and had more comorbidities (p < 0.01) than the non-hypertensive group. In laboratory tests, hypertensive patients had higher levels of blood glucose (p = 0.014), creatinine (p = 0.002), and urea (p = 0.003), while values for alanine aminotransferase (ALT) (p < 0.01), aspartate aminotransferase (AST) (p = 0.006), and sodium (p = 0.024) were lower. There was no difference between groups in radiographic parameters. Conclusions This study showed that, although the hypertensive group had some laboratory alterations that elicited severe disease, these patients did not have worse outcomes.
背景鉴于COVID-19缺乏有效的治疗方法,许多研究试图确定严重形式发展的决定因素,旨在指导努力避免易感重症患者的最坏结局。与复杂形式的疾病相关的主要合并症之一是全身性动脉高血压(SAH)。目的评估高血压合并COVID-19患者的临床、人口学、实验室和影像学特征,以了解这种合并症的存在与疾病严重程度之间的关系。方法收集2020年6月至8月收治的急性SARS-CoV-2感染患者380例。根据既往是否有高血压诊断,将患者分为两组。组间比较以p < 0.05为差异有统计学意义。结果380例患者中,202例(53.16%)临床诊断为SAH。高血压组患者年龄明显大于非高血压组(p < 0.01),合并症发生率明显高于非高血压组(p < 0.01)。在实验室检测中,高血压患者血糖(p = 0.014)、肌酐(p = 0.002)和尿素(p = 0.003)水平较高,而丙氨酸转氨酶(ALT) (p < 0.01)、天冬氨酸转氨酶(AST) (p = 0.006)和钠(p = 0.024)水平较低。两组间放射学参数无差异。结论:本研究表明,尽管高血压组有一些引起严重疾病的实验室改变,但这些患者的预后并不差。
{"title":"Clinical Aspects Of Hypertensive Patients With COVID-19 Hospitalized In A Campaign Hospital In Northeast Brazil","authors":"Luan George Xavier, Renato Sampaio Mello, Marcos Henrique de Oliveira Morais, Pedro Jorge Luz Alves Cronemberger, M. D. C. C. Martins, M. Rosal","doi":"10.36660/ijcs.20220033","DOIUrl":"https://doi.org/10.36660/ijcs.20220033","url":null,"abstract":"Abstract Background In view of the absence of effective therapy for COVID-19, many studies have been conducted seeking to identify determining factors for the development of severe forms, aiming to direct efforts to avoid the worst outcomes in patients susceptible to severe conditions. One of the main comorbidities associated with complicated forms of the disease is systemic arterial hypertension (SAH). Objective To assess aspects of the clinical, demographic, laboratory, and radiological characteristics of hypertensive patients with COVID-19 to contribute to the knowledge of the relationship between the presence of this comorbidity and the severity of the disease. Methods A total of 380 patients with a diagnosis of acute SARS-CoV-2 infection hospitalized between June and August 2020 were included. Patients were divided into two groups according to the presence or absence of a previous diagnosis of hypertension. For comparison between groups, a significant difference was established if p < 0.05. Results Of the total of 380 patients, 202 (53.16%) had a clinical diagnosis of SAH. Hypertensive patients were significantly older (p < 0.01) and had more comorbidities (p < 0.01) than the non-hypertensive group. In laboratory tests, hypertensive patients had higher levels of blood glucose (p = 0.014), creatinine (p = 0.002), and urea (p = 0.003), while values for alanine aminotransferase (ALT) (p < 0.01), aspartate aminotransferase (AST) (p = 0.006), and sodium (p = 0.024) were lower. There was no difference between groups in radiographic parameters. Conclusions This study showed that, although the hypertensive group had some laboratory alterations that elicited severe disease, these patients did not have worse outcomes.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"157 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90420822","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Is Age Associated with Complications of Atrial Fibrillation Catheter Ablation? 房颤导管消融的并发症与年龄有关吗?
Q4 Medicine Pub Date : 2023-04-03 DOI: 10.36660/ijcs.20210241
C. Lovatto, Vinicius Louback Baldon, Júlia Henriques, F. Vassallo, Eduardo Serpa, A. Simões, Hermes Carloni, C. Cunha, Dalbian Gasparini, R. Barbosa, O. Calil, R. Serpa, L. Barbosa
Abstract Background Atrial fibrillation (AF) is the most frequent arrhythmia, and its prevalence increases with age. The management of AF in the elderly is challenging, as it is normally associated with comorbidities and frailty. AF catheter ablation (CA) is a safe and superior alternative to antiarrhythmic drugs (AADs) for the maintenance of sinus rhythm. Objectives To evaluate the rate of complications associated with CA for AF across different age groups. Methods A retrospective analysis of 219 patients who underwent CA for AF between 2016 and 2020 were divided into 3 age groups: less than 60 years, 60 to 70 years, and > 70 years. All the included patients underwent radiofrequency ablation using an electroanatomic mapping system. Categorical variables were evaluated with chi-square and Fisher’s test, and continuous variables were evaluated by Kruskal-Wallis and post-hoc Tamhane’s T2. P values less than 0.05 were considered significant. Results We found an overall total complication rate of 4.6%. The total complication rate was 3.3% in patients < 60 years of age, 5.7% in patients between 60 and 70 years, and 5.2% in patients > 70 years (p = 0.742). No deaths occurred. Conclusion There was no significant difference in the AF CA-related complications when comparing the patients by age group.
{"title":"Is Age Associated with Complications of Atrial Fibrillation Catheter Ablation?","authors":"C. Lovatto, Vinicius Louback Baldon, Júlia Henriques, F. Vassallo, Eduardo Serpa, A. Simões, Hermes Carloni, C. Cunha, Dalbian Gasparini, R. Barbosa, O. Calil, R. Serpa, L. Barbosa","doi":"10.36660/ijcs.20210241","DOIUrl":"https://doi.org/10.36660/ijcs.20210241","url":null,"abstract":"Abstract Background Atrial fibrillation (AF) is the most frequent arrhythmia, and its prevalence increases with age. The management of AF in the elderly is challenging, as it is normally associated with comorbidities and frailty. AF catheter ablation (CA) is a safe and superior alternative to antiarrhythmic drugs (AADs) for the maintenance of sinus rhythm. Objectives To evaluate the rate of complications associated with CA for AF across different age groups. Methods A retrospective analysis of 219 patients who underwent CA for AF between 2016 and 2020 were divided into 3 age groups: less than 60 years, 60 to 70 years, and > 70 years. All the included patients underwent radiofrequency ablation using an electroanatomic mapping system. Categorical variables were evaluated with chi-square and Fisher’s test, and continuous variables were evaluated by Kruskal-Wallis and post-hoc Tamhane’s T2. P values less than 0.05 were considered significant. Results We found an overall total complication rate of 4.6%. The total complication rate was 3.3% in patients < 60 years of age, 5.7% in patients between 60 and 70 years, and 5.2% in patients > 70 years (p = 0.742). No deaths occurred. Conclusion There was no significant difference in the AF CA-related complications when comparing the patients by age group.","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81888408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Challenges of Implementing a Text Message Intervention to Promote Behavioral Change in Primary Care Patients With Hypertension and Diabetes 实施短信干预促进高血压和糖尿病初级保健患者行为改变的挑战
Q4 Medicine Pub Date : 2023-04-03 DOI: 10.36660/ijcs.20220050
J. A. Oliveira, C. Cimini, Vania Almeida, J. Maia, Raissa Eda Resende, Leticia Alves Gualberto, Pedro Henrique Lauar Santos, P. R. Gomes, Leonardo Bonisson, Maria Cristina da Paixão, Janaina Moutinho Costa, C. Cardoso, K. Santo, A. Ribeiro, M. Martins, M. Marcolino
,
{"title":"The Challenges of Implementing a Text Message Intervention to Promote Behavioral Change in Primary Care Patients With Hypertension and Diabetes","authors":"J. A. Oliveira, C. Cimini, Vania Almeida, J. Maia, Raissa Eda Resende, Leticia Alves Gualberto, Pedro Henrique Lauar Santos, P. R. Gomes, Leonardo Bonisson, Maria Cristina da Paixão, Janaina Moutinho Costa, C. Cardoso, K. Santo, A. Ribeiro, M. Martins, M. Marcolino","doi":"10.36660/ijcs.20220050","DOIUrl":"https://doi.org/10.36660/ijcs.20220050","url":null,"abstract":",","PeriodicalId":32690,"journal":{"name":"International Journal of Cardiovascular Sciences","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73989435","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International Journal of Cardiovascular Sciences
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1